Pathogenesis of bronchopulmonary dysplasia

Respiration

Volumn 79, Issue 5, 2010, Pages 425-436

  Hayes Jr , Don ^b   Feola, David J ^a   Murphy, Brian S ^b   Shook, Lori A ^b   Ballard, Hubert O ^b  

^a University of Kentucky   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease of infancy; Pathogenesis; Pathophysiology

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; AZITHROMYCIN; BIOLOGICAL MARKER; CHEMOKINE RECEPTOR ANTAGONIST; CONNECTIVE TISSUE GROWTH FACTOR; COPPER ZINC SUPEROXIDE DISMUTASE; DIPEPTIDYL CARBOXYPEPTIDASE; ERYTHROMYCIN; GLUTATHIONE TRANSFERASE; INTERLEUKIN 6; LUNG SURFACTANT; MALONALDEHYDE; RETINOL; SB 265610; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADRENAL INSUFFICIENCY; ARTIFICIAL VENTILATION; CHORIOAMNIONITIS; CLINICAL TRIAL; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; INFLAMMATION; LUNG ALVEOLUS; LUNG DEVELOPMENT; LUNG DYSPLASIA; MEDICAL LITERATURE; NONHUMAN; NUTRITION; OXYGEN TOXICITY; PATENT DUCTUS ARTERIOSUS; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; UREAPLASMA INFECTION;

ADRENAL INSUFFICIENCY; ANTIOXIDANTS; BRONCHOPULMONARY DYSPLASIA; DUCTUS ARTERIOSUS, PATENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; INFANT, PREMATURE; INFLAMMATION; LUNG; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; RESPIRATORY TRACT INFECTIONS;

EID: 77951295567     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000242497     Document Type: Review

References (122)

1. Northway WH Jr, Rosan RC, Porter DY: Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967; 276: 357-368.
2. Pusey VA, Macpherson RI, Chernick V: Pulmonary fibroplasia following prolonged artificial ventilation of newborn infants. Can Med Assoc J 1969; 100: 451-457.
3. Kraybill EN, Runyan DK, Bose CL, Khan JH: Risk factors for chronic lung disease in infants with birth weights of 751 to 1000 grams. J Pediatr 1989; 115: 115-120.
4. Sinkin RA, Cox C, Phelps DL: Predicting risk for bronchopulmonary dysplasia: selection criteria for clinical trials. Pediatrics 1990; 86: 728-736. (Pubitemid 20379402)
5. Shennan AT, Dunn MS, Ohlsson A, et al: Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82: 527-532.
6. Marshall DD, Kotelchuck M, Young TE, Bose CL, Kruyer L, O'Shea TM: Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association. Pediatrics 1999; 104: 1345-1350.
7. Jobe AH, Bancalari E: Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-1729. (Pubitemid 32578778)
8. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, Wrage LA, Poole K, National Institutes of Child Health and Human Development Neonatal Research Network: Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116: 1353-1360. (Pubitemid 46056482)
9. Cherukupalli K, Larson JE, Rotschild A, Thurlbeck WM: Biochemical, clinical, and morphologic studies on lungs of infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1996; 22: 215-229. (Pubitemid 26363856)
10. Husain AN, Siddiqui NH, Stocker JT: Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998; 29: 710-717.
11. Coalson JJ: Pathology of new bronchopulmonary dysplasia. Semin Neonatol 2003; 8: 73-81.
12. Langston C, Thurlbeck WM: Lung growth and development in late gestation and early postnatal life. Perspect Pediatr Pathol 1982; 7: 203-235.
13. Langston C, Kida K, Reed M, Thurlbeck WM: Human lung growth in late gestation and in the neonate. Am Rev Respir Dis 1984; 129: 607-613. (Pubitemid 14126782)
14. Burri PH: Structural aspects of prenatal and postnatal development and growth of the lung; in McDonald JA (ed): Structural Aspects of Prenatal and Postnatal Development and Growth of the Lung. New York, Dekker, 1997, pp 1-35.
15. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, Abman SH: Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 2000; 279:L600-L607.
16. Abman SH: Bronchopulmonary dysplasia: 'a vascular hypothesis'. Am J Respir Crit Care Med 2001; 164: 1755-1756.
17. Hislop AA: Airway and blood vessel interaction during lung development. J Anat 2002; 201: 325-334. (Pubitemid 35244052)
18. Hall SM, Hislop AA, Haworth SG: Origin, differentiation, and maturation of human pulmonary veins. Am J Respir Cell Mol Biol 2002; 26: 333-340. (Pubitemid 34170059)
19. Maniscalco WM, Watkins RH, Pryhuber GS, Bhatt A, Shea C, Huyck H: Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol 2002; 282:L811-L823. (Pubitemid 34665598)
20. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM: Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 164: 1971-1980. (Pubitemid 33152338)
21. Lassus P, Turanlahti M, Heikkila P, Andersson LC, Nupponen I, Sarnesto A, Andersson S: Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 2001; 164: 1981-1987. (Pubitemid 33152339)
22. Thebaud B, Ladha F, Michelakis ED, Sawicka M, Thurston G, Eaton F, Hashimoto K, Harry G, Haromy A, Korbutt G, Archer SL: Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia- induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 2005; 112: 2477-2486. (Pubitemid 41504498)
23. Bhandari V, Choo-Wing R, Lee CG, Yusuf K, Nedrelow JH, Ambalavanan N, Malkus H, Homer RJ, Elias JA: Developmental regulation of NO-mediated VEGF-induced effects in the lung. Am J Respir Cell Mol Biol 2008; 39: 420-430.
24. Escobedo MB, Hilliard JL, Smith F, Meredith K, Walsh W, Johnson D, Coalson JJ, Kuehl TJ, Null DM Jr, Robotham JL: A baboon model of bronchopulmonary dysplasia. I. Clinical features. Exp Mol Pathol 1982; 37: 323-334. (Pubitemid 13170323)
25. Welty SE, Smith CV: Rationale for antioxidant therapy in premature infants to prevent bronchopulmonary dysplasia. Nutr Rev 2001; 59: 10-17. (Pubitemid 32193239)
26. Welty SE: Antioxidants and oxidations in bronchopulmonary dysplasia: there are no easy answers. J Pediatr 2003; 143: 697-698.
27. Asikainen TM, White CW: Pulmonary antioxidant defenses in the preterm newborn with respiratory distress and bronchopulmonary dysplasia in evolution: implications for antioxidant therapy. Antioxid Redox Signal 2004; 6: 155-167.
28. Asikainen TM, Raivio KO, Saksela M, Kinnula VL: Expression and developmental profile of antioxidant enzymes in human lung and liver. Am J Respir Cell Mol Biol 1998; 19: 942-949. (Pubitemid 128354293)
29. Fu RH, Chiu TH, Chiang MC, Lien R, Chou YH, Chiang CC, Cho YH, Yang PH: Lower erythrocyte glutathione peroxidase activity in bronchopulmonary dysplasia in the first week of neonatal life. Neonatology 2008; 93: 269-275. (Pubitemid 351799108)
30. Jain A, Mehta T, Auld PA, Rodrigues J, Ward RF, Schwartz MK, Martensson J: Glutathione metabolism in newborns: evidence for glutathione deficiency in plasma, bronchoalveolar lavage fluid, and lymphocytes in prematures. Pediatr Pulmonol 1995; 20: 160-166.
31. Moison RM, Haasnoot AA, van Zoeren-Grobben D, Berger HM: Red blood cell glutathione and plasma sulfhydryls in chronic lung disease of the newborn. Acta Paediatr 1997; 86: 1363-1369.
32. Ahola T, Lapatto R, Raivio KO, Selander B, Stigson L, Jonsson B, Jonsbo F, Esberg G, Stovring S, Kjartansson S, Stiris T, Lossius K, Virkola K, Fellman V: N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: a randomized controlled trial. J Pediatr 2003; 143: 713-719. (Pubitemid 37510637)
33. Shenai JP, Chytil F, Jhaveri A, Stahlman MT: Plasma vitamin A and retinol-binding protein in premature and term neonates. J Pediatr 1981; 99: 302-305. (Pubitemid 11046516)
34. 2 -induced inhibition of lung septation. Am J Physiol Lung Cell Mol Physiol 2002; 283: L971-L980.
35. Bland RD, Albertine KH, Pierce RA, Starcher BC, Carlton DP: Impaired alveolar development and abnormal lung elastin in preterm lambs with chronic lung injury: potential benefits of retinol treatment. Biol Neonate 2003; 84: 101-102.
36. Darlow BA, Graham PJ: Vitamin A supplementation for preventing morbidity and mortality in very low birth weight infants (review). Cochrane Database Syst Rev 2002; 4:CD000501.
37. Tyson JE, Wright LL, Oh W, Kennedy KA, Mele L, Ehrenkranz RA, Stoll BJ, Lemons JA, Stevenson DK, Bauer CR, Korones SB, Fanaroff AA: Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 1999; 340: 1962-1968. (Pubitemid 29288272)
38. Watts JL, Milner R, Zipursky A, Paes B, Ling E, Gill G, Fletcher B, Rand C: Failure of supplementation with vitamin E to prevent bronchopulmonary dysplasia in infants less than 1,500 g birth weight. Eur Respir J 1991; 4: 188-190.
39. Davis JM, Parad RB, Michele T, Allred E, Price A, Rosenfeld W, North American Recombinant Human CuZnSOD Study Group: Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics 2003; 111: 469-476. (Pubitemid 36330700)
40. Frank L: Antioxidants, nutrition, and bronchopulmonary dysplasia. Clin Perinatol 1992; 19: 541-562.
41. Varsila E, Pesonen E, Andersson S: Early protein oxidation in the neonatal lung is related to development of chronic lung disease. Acta Paediatr 1995; 84: 1296-1299.
42. Varsila E, Hallman M, Andersson S: Freeradical- induced lipid peroxidation during the early neonatal period. Acta Paediatr 1994; 83: 692-695. (Pubitemid 24248816)
43. Collard KJ, Godeck S, Holley JE, Quinn MW: Pulmonary antioxidant concentrations and oxidative damage in ventilated premature babies. Arch Dis Child Fetal Neonatal Ed 2004; 89:F412-F416. (Pubitemid 39178817)
44. Taghizadeh A, Reynolds EO: Pathogenesis of bronchopulmonary dysplasia following hyaline membrane disease. Am J Pathol 1976; 82: 241-264.
45. Stahlman M, Hedvall G, Lindstrom D, Snell J: Role of hyaline membrane disease in production of later childhood lung abnormalities. Pediatrics 1982; 69: 572-576. (Pubitemid 12155926)
46. Albertine KH, Jones GP, Starcher BC, Bohnsack JF, Davis PL, Cho SC, Carlton DP, Bland RD: Chronic lung injury in preterm lambs. Disordered respiratory tract development. Am J Respir Crit Care Med 1999; 159: 945-958.
47. Garland JS, Buck RK, Allred EN, Leviton A: Hypocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome. Arch Pediatr Adolesc Med 1995; 149: 617-622.
48. Bjorklund LJ, Vilstrup CT, Larsson A, Svenningsen NW, Werner O: Changes in lung volume and static expiratory pressure-volume diagram after surfactant rescue treatment of neonates with established respiratory distress syndrome. Am J Respir Crit Care Med 1996; 154: 918-923. (Pubitemid 126679525)
49. Bland RD, Mokres LM, Ertsey R, Jacobson BE, Jiang S, Rabinovitch M, Xu L, Shinwell ES, Zhang F, Beasley MA: Mechanical ventilation with 40% oxygen reduces pulmonary expression of genes that regulate lung development and impairs alveolar septation in newborn mice. Am J Physiol Lung Cell Mol Physiol 2007; 293:L1099-L1110. (Pubitemid 350159394)
50. Bland RD, Ertsey R, Mokres LM, Xu L, Jacobson BE, Jiang S, Alvira CM, Rabinovitch M, Shinwell ES, Dixit A: Mechanical ventilation uncouples synthesis and assembly of elastin and increases apoptosis in lungs of newborn mice. Prelude to defective alveolar septation during lung development? Am J Physiol Lung Cell Mol Physiol 2008; 294:L3-L14. (Pubitemid 351380312)
51. Sawyer MH, Edwards DK, Spector SA: Cytomegalovirus infection and bronchopulmonary dysplasia in premature infants. Am J Dis Child 1987; 141: 303-305. (Pubitemid 17019935)
52. Cassell GH, Waites KB, Crouse DT, Rudd PT, Canupp KC, Stagno S, Cutter GR: Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants. Lancet 1988;ii:240-245.
53. Abele-Horn M, Genzel-Boroviczeny O, Uhlig T, Zimmermann A, Peters J, Scholz M: Ureaplasma urealyticum colonization and bronchopulmonary dysplasia: a comparative prospective multicentre study. Eur J Pediatr 1998; 157: 1004-1011. (Pubitemid 28559753)
54. Benstein BD, Crouse DT, Shanklin DR, Ourth DD: Ureaplasma in lung. 2. Association with bronchopulmonary dysplasia in premature newborns. Exp Mol Pathol 2003; 75: 171-177.
55. Mabanta CG, Pryhuber GS, Weinberg GA, Phelps DL: Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum. Cochrane Database Syst Rev 2003; 4:CD003744.
56. Ballard HO, Bernard P, Qualls J, Everson W, Shook LA: Azithromycin protects against hyperoxic lung injury in neonatal rats. J Investig Med 2007; 55: 299-305. (Pubitemid 350205424)
57. Ballard HO, Bernard PA, Hayes D, Anstead MI, Desai NS, Smart EJ, Kryscio R, Shook LA: Use of azithromycin for the prevention of bronchopulmonary dysplasia: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med 2009; 179: A4126.
58. Bhandari V, Hussain N, Rosenkrantz T, Kresch M: Respiratory tract colonization with mycoplasma species increases the severity of bronchopulmonary dysplasia. J Perinat Med 1998; 26: 37-42. (Pubitemid 28154326)
59. Watterberg KL, Demers LM, Scott SM, Murphy S: Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97: 210-215. (Pubitemid 26049651)
60. Kramer BW, Ikegami M, Jobe AH: Intratracheal endotoxin causes systemic inflammation in ventilated preterm lambs. Am J Respir Crit Care Med 2002; 165: 463-469. (Pubitemid 34165468)
61. Young KC, Del Moral T, Claure N, Vanbuskirk S, Bancalari E: The association between early tracheal colonization and bronchopulmonary dysplasia. J Perinatol 2005; 25: 403-407. (Pubitemid 40862205)
62. Kunzmann S, Speer CP, Jobe AH, Kramer BW: Antenatal inflammation induced TGF-β 1 but suppressed CTGF in preterm lungs. Am J Physiol Lung Cell Mol Physiol 2007; 292:L223-L231. (Pubitemid 46103447)
63. Li YH, Tullus K: Microbial infection and inflammation in the development of chronic lung disease of prematurity. Microbes Infect 2002; 4: 723-732. (Pubitemid 34626985)
64. Jobe AH: Antenatal factors and the development of bronchopulmonary dysplasia. Semin Neonatol 2003; 8: 9-17.
65. Speer CP: Inflammation and bronchopulmonary dysplasia. Semin Neonatol 2003; 8: 29-38.
66. Sarafidis K, Drossou-Agakidou V, Kanakoudi- Tsakalidou F, Taparkou A, Tsakalidis C, Tsandali C, Kremenopoulos G: Evidence of early systemic activation and transendothelial migration of neutrophils in neonates with severe respiratory distress syndrome. Pediatr Pulmonol 2001; 31: 214-219. (Pubitemid 32230576)
67. Munshi UK, Niu JO, Siddiq MM, Parton LA: Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr Pulmonol 1997; 24: 331-336.
68. Kotecha S, Wilson L, Wangoo A, Silverman M, Shaw RJ: Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res 1996; 40: 250-256. (Pubitemid 26249677)
69. Watterberg KL, Scott SM, Backstrom C, Gifford KL, Cook KL: Links between early adrenal function and respiratory outcome in preterm infants: airway inflammation and patent ductus arteriosus. Pediatrics 2000; 105: 320-324. (Pubitemid 30078671)
70. Banks BA, Stouffer N, Cnaan A, Ning Y, Merrill JD, Ballard RA, Ballard PL, North American Thyrotropin-Releasing Hormone Trial Collaborators: Association of plasma cortisol and chronic lung disease in preterm infants. Pediatrics 2001; 107: 494-498. (Pubitemid 32183182)
71. Brown ER: Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus. J Pediatr 1979; 95: 865-866. (Pubitemid 10209777)
72. Gonzalez A, Sosenko IR, Chandar J, Hummler H, Claure N, Bancalari E: Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr 1996; 128: 470-478. (Pubitemid 26114083)
73. Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G: Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995; 126: 605-610.
74. Bhandari V, Gruen JR: The genetics of bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 185-191. (Pubitemid 44062676)
75. Kazzi SN, Quasney MW: Deletion allele of angiotensin-converting enzyme is associated with increased risk and severity of bronchopulmonary dysplasia. J Pediatr 2005; 147: 818-822.
76. Manar MH, Brown MR, Gauthier TW, Brown LA: Association of glutathione-Stransferase- P1 (GST-P1) polymorphisms with bronchopulmonary dysplasia. J Perinatol 2004; 24: 30-35. (Pubitemid 38159800)
77. Weber B, Borkhardt A, Stoll-Becker S, Reiss I, Gortner L: Polymorphisms of surfactant protein A genes and the risk of bronchopulmonary dysplasia in preterm infants. Turk J Pediatr 2000; 42: 181-185.
78. Rova M, Haataja R, Marttila R, Ollikainen V, Tammela O, Hallman M: Data mining and multiparameter analysis of lung surfactant protein genes in bronchopulmonary dysplasia. Hum Mol Genet 2004; 13: 1095-1104. (Pubitemid 38786992)
79. Kazzi SN, Kim UO, Quasney MW, Buhimschi I: Polymorphism of tumor necrosis factor- alpha and risk and severity of bronchopulmonary dysplasia among very low birth weight infants. Pediatrics 2004; 114:e243-e248.
80. Pryhuber GS, Huyck HL, Staversky RJ, Finkelstein JN, O'Reilly MA: Tumor necrosis factor-alpha-induced lung cell expression of antiapoptotic genes TRAF1 and cIAP2. Am J Respir Cell Mol Biol 2000; 22: 150-156.
81. Murch SH, MacDonald TT, Wood CB, Costeloe KL: Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment. Thorax 1992; 47: 44-47.
82. Tullus K, Noack GW, Burman LG, Nilsson R, Wretlind B, Brauner A: Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia. Eur J Pediatr 1996; 155: 112-116. (Pubitemid 126422137)
83. Coalson JJ, Winter VT, Siler-Khodr T, Yoder BA: Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 1999; 160: 1333-1346. (Pubitemid 29487478)
84. Strassberg SS, Cristea IA, Qian D, Parton LA: Single nucleotide polymorphisms of tumor necrosis factor-alpha and the susceptibility to bronchopulmonary dysplasia. Pediatr Pulmonol 2007; 42: 29-36. (Pubitemid 46080150)
85. Sobel DB, Carroll A: Postsurfactant slump: early prediction of neonatal chronic lung disease? J Perinatol 1994; 14: 268-274.
86. Merrill JD, Ballard RA, Cnaan A, Hibbs AM, Godinez RI, Godinez MH, Truog WE, Ballard PL: Dysfunction of pulmonary surfactant in chronically ventilated premature infants. Pediatr Res 2004; 56: 918-926. (Pubitemid 39552774)
87. ter Horst SA, Fijlstra M, Sengupta S, Walther FJ, Wagenaar GT: Spatial and temporal expression of surfactant proteins in hyperoxiainduced neonatal rat lung injury. BMC Pulm Med 2006; 6: 8. (Pubitemid 43880491)
88. Coalson JJ, King RJ, Yang F, Winter V, Whitsett JA, Delemos RA, Seidner SR: SP-A deficiency in primate model of bronchopulmonary dysplasia with infection. In situ mRNA and immunostains. Am J Respir Crit Care Med 1995; 151: 854-866.
89. King RJ, Coalson JJ, deLemos RA, Gerstmann DR, Seidner SR: Surfactant protein-A deficiency in a primate model of bronchopulmonary dysplasia. Am J Respir Crit Care Med 1995; 151: 1989-1997.
90. Strayer DS, Merritt TA, Hallman M: Levels of SP-A-anti-SP-A immune complexes in neonatal respiratory distress syndrome correlate with subsequent development of bronchopulmonary dysplasia. Acta Paediatr 1995; 84: 128-131.
91. Ryan SF, Ghassibi Y, Liau DF: Effects of activated polymorphonuclear leukocytes upon pulmonary surfactant in vitro. Am J Respir Cell Mol Biol 1991; 4: 33-41.
92. Jefferies AL, Coates G, O'Brodovich H: Pulmonary epithelial permeability in hyalinemembrane disease. N Engl J Med 1984; 311: 1075-1080. (Pubitemid 14012517)
93. Ikegami M, Jacobs H, Jobe A: Surfactant function in respiratory distress syndrome. J Pediatr 1983; 102: 443-447. (Pubitemid 13149477)
94. Seeger W, Grube C, Gunther A, Schmidt R: Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 1993; 6: 971-977. (Pubitemid 23221331)
95. Griese M, Westerburg B: Surfactant function in neonates with respiratory distress syndrome. Respiration 1998; 65: 136-142. (Pubitemid 28154298)
96. Cogo PE, Simonato M, Mariatoffolo G, Stefanutti G, Chierici M, Cobelli C, Ori C, Carnielli VP: Dexamethasone therapy in preterm infants developing bronchopulmonary dysplasia: effect on pulmonary surfactant disaturated- phosphatidylcholine kinetics. Pediatr Res 2008; 63: 433-437. (Pubitemid 351450593)
97. Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer D, Edwards DK 3rd, Gluck L: Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J Clin Invest 1983; 72: 656-666. (Pubitemid 13051327)
98. Rozycki HJ: Bronchoalveolar interleukin-1 beta in infants on day 1 of life. South Med J 1994; 87: 991-996.
99. Rindfleisch MS, Hasday JD, Taciak V, Broderick K, Viscardi RM: Potential role of interleukin-1 in the development of bronchopulmonary dysplasia. J Interferon Cytokine Res 1996; 16: 365-373. (Pubitemid 26161715)
100. Dinarell CA, Wolff SM: The role of interleukin-1 in disease. N Engl J Med 1993; 328: 106-113.
101. Hernandez A, Omini C, Daffonchio L: Interleukin-1 beta: a possible mediator of lung inflammation and airway hyperreactivity. Pharmacol Res 1991; 24: 385-393.
102. Bagchi A, Viscardi RM, Taciak V, Ensor JE, McCrea KA, Hasday JD: Increased activity of interleukin-6 but not tumor necrosis factor- alpha in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia. Pediatr Res 1994; 36: 244-252. (Pubitemid 24222488)
103. Choi CW, Kim BI, Kim HS, Park JD, Choi JH, Son DW: Increase of interleukin-6 in tracheal aspirate at birth: a predictor of subsequent bronchopulmonary dysplasia in preterm infants. Acta Paediatr 2006; 95: 38-43.
104. Patterson AM, Taciak V, Lovchik J, Fox RE, Campbell AB, Viscardi RM: Ureaplasma urealyticum respiratory tract colonization is associated with an increase in interleukin 1-beta and tumor necrosis factor alpha relative to interleukin 6 in tracheal aspirates of preterm infants. Pediatr Infect Dis J 1998; 17: 321-328. (Pubitemid 28208206)
105. Ogden BE, Murphy SA, Saunders GC, Pathak D, Johnson JD: Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis 1984; 130: 817-821.
106. Tan ND, Davidson D: Comparative differences and combined effects of interleukin- 8, leukotriene B4, and platelet-activating factor on neutrophil chemotaxis of the newborn. Pediatr Res 1995; 38: 11-16.
107. Su BH, Chiu HY, Lin TW, Lin HC: Interleukin-8 in bronchoalveolar lavage fluid of premature infants at risk of chronic lung disease. J Formos Med Assoc 2005; 104: 244-248.
108. Deng H, Mason SN, Auten RL Jr: Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats. Am J Respir Crit Care Med 2000; 162: 2316-2323. (Pubitemid 32051706)
109. Yi M, Jankov RP, Belcastro R, Humes D, Copland I, Shek S, Sweezey NB, Post M, Albertine KH, Auten RL, Tanswell AK: Opposing effects of 60% oxygen and neutrophil influx on alveologenesis in the neonatal rat. Am J Respir Crit Care Med 2004; 170: 1188-1196. (Pubitemid 39577377)
110. Jones CA, Cayabyab RG, Kwong KY, Stotts C, Wong B, Hamdan H, Minoo P, deLemos RA: Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996; 39: 966-975. (Pubitemid 126425805)
111. Bose CL, Dammann CE, Laughon MM: Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Child Fetal Neonatal Ed 2008; 93:F455-F461.
112. Ryan RM, Ahmed Q, Lakshminrusimha S: Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia. Clin Rev Allergy Immunol 2008; 34: 174-190.
113. Kallapur SG, Jobe AH: Contribution of inflammation to lung injury and development. Arch Dis Child Fetal Neonatal Ed 2006; 91:F132-F135. (Pubitemid 43325534)
114. Halliday H, Hirschfeld S, Riggs T, Liebman J, Fanaroff A, Bormuth C: Respiratory distress syndrome: echocardiographic assessment of cardiovascular function and pulmonary vascular resistance. Pediatrics 1977; 60: 444-449. (Pubitemid 8208120)
115. Evans NJ, Archer LN: Doppler assessment of pulmonary artery pressure and extrapulmonary shunting in the acute phase of hyaline membrane disease. Arch Dis Child 1991; 66: 6-11.
116. Evans NJ, Archer LN: Doppler assessment of pulmonary artery pressure during recovery from hyaline membrane disease. Arch Dis Child 1991; 66: 802-804.
117. Walther FJ, Benders MJ, Leighton JO: Persistent pulmonary hypertension in premature neonates with severe respiratory distress syndrome. Pediatrics 1992; 90: 899-904.
118. Gill AB, Weindling AM: Pulmonary artery pressure changes in the very low birthweight infant developing chronic lung disease. Arch Dis Child 1993; 68: 303-307.
119. Subhedar NV, Shaw NJ: Changes in pulmonary arterial pressure in preterm infants with chronic lung disease. Arch Dis Child Fetal Neonatal Ed 2000; 82:F243-F247. (Pubitemid 30313563)
120. Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC, Mullen MP: Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 2007; 120: 1260-1269. (Pubitemid 350223677)
121. Mourani PM, Ivy DD, Gao D, Abman SH: Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia. Am J Respir Crit Care Med 2004; 170: 1006-1013. (Pubitemid 39425698)
122. Mourani PM, Sontag MK, Younoszai A, Ivy DD, Abman SH: Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics 2008; 121: 317-325. (Pubitemid 351198454)